Efficacy of HPV-16 E7 based vaccine in a TC-1 tumoric animal model of cervical cancer

Yakhteh

Volumn 12, Issue 4, 2011, Pages 483-488

  Fazeli, Maryam ^a   Soleimanjahi, Hoorieh ^a   Ghaemi, Amir ^a   Farzanepour, Mahdieh ^a   Amanzadeh, Amir ^b   Hashemi, Seyed Reza ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

C57BL mice; DNA vaccine; TC 1

Indexed keywords

ANTIBIOTIC AGENT; DNA VACCINE; GLUTAMINE; HPV 16 E7 BASED VACCINE; PHOSPHATE BUFFERED SALINE; PLASMID DNA; UNCLASSIFIED DRUG;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN PAPILLOMAVIRUS TYPE 16; MITOSIS; MOUSE; NONHUMAN; PRACTICE GUIDELINE; PROTEIN EXPRESSION; STAINING; STATISTICAL SIGNIFICANCE; TUMOR CELL LINE; TUMOR GROWTH; TUMOR VOLUME; UTERINE CERVIX CANCER;

EID: 80052070486     PISSN: 15614921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Smith HO, Tiffany MF, Qualls CR, Key CR. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States - a 24-year population-based study. Gynecol Oncol. 2000; 78(2): 97-105.
2. Mohar A, Frias-Mendivil M. Epidemiology of cervical cancer. Cancer Invest. 2000; 18(6): 584-90.
3. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995; 87(11): 796-802.
4. La Torre G, de Waure C, Chiaradia G, Mannocci A, Ricciardi W. HPV vaccine efficacy in preventing persistent cervical HPV infection: a systematic review and metaanalysis. Vaccine. 2007; 25(50): 8352-8358.
5. Niakan M, Eftekhar Z, Jamali Zavareh M,Golalipour F, Faghihzadeh S, Jalali MR. Human Papillomavirus genotype as a major determinant of the course of cervical cancer. Yakhteh Medical Journal. 2004; 5(20):154-157.
6. Wu TC, Hsieh ST, Purow BW, Kurman RJ. Demonstration of human papillomavirus (HPV) genomic amplification and viral-like particles from CaSki cell line in SCID mice. J Virol Methods. 1997; 65(2): 287-298.
7. Heard I, Tassie JM, Schmitz V, Mandelbrot L, Kazatchkine MD, Orth G. Increased risk of cervical disease among human immunodeficiency virus-infected women with severe immunosuppression and high human papillomavirus load(1). Obstet Gynecol. 2000; 96(3): 403-409.
8. Chen CH, Ji H, Suh KW, Choti MA, Pardoll DM, Wu TC. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs. Gene Ther. 1999; 6(12): 1972-1981.
9. Lin KY, Guarnieri FG, Staveley-O'Carroll KF, Levitsky HI, August JT, Pardoll DM, et al. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 1996; 56(1): 21-26.
10. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet. 2004; 364(9447): 1757-1765.
11. Meshkat Z, Soleimanjahi H, Mahmoudi M, Hassan ZM, Mirshahabi H, Meshkat M, et al. CTL responses to a DNA vaccine encoding E7 gene of human papillomavirus type 16 from an Iranian isolate. Iran J Immunol. 2008; 5(2): 82-91.
12. Sambrook J, Russel D. Molocular Cloning. 2001; AI.19-AI.24
13. Li Y, Subjeck J, Yang G, Repasky E, Wang XY. Generation of anti-tumor immunity using mammalian heat shock protein 70 DNA vaccines for cancer immunotherapy. Vaccine. 2006; 24(25): 5360-5370.
14. zur Hausen H. Papillomavirus infections - a major cause of human cancers. Biochim Biophys Acta. 1996; 1288(2): F55-78.
15. Han L, Wang W, Fang Y, Feng Z, Liao S, Li W, et al. Soluble B and T lymphocyte attenuator possesses anti-tumor effects and facilitates heat shock protein 70 vaccine-triggered antitumor immunity against a murine TC-1 cervical cancer model in vivo. J Immunol. 2009; 183(12): 7842-7850.
16. HPV Vaccine Information For Young Women. Centers for Disease Control and Prevention (CDC). Available from: URL://www.cdc.gov/std/hpv/STDFact-HPV-vaccine- young-women.htm. Retrieved 13 Feb 2010.
17. Brinkman JA, Xu X, Kast WM. The efficacy of a DNA vaccine containing inserted and replicated regions of the E7 gene for treatment of HPV-16 induced tumors. Vaccine. 2007; 25(17): 3437-3444.
18. Feltkamp MC, Smits HL, Vierboom MP, Minnaar RP, de Jong BM, Drijfhout JW, et al. Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol. 1993; 23(9): 2242-2249.